FIELD: biochemistry.
SUBSTANCE: invention relates to biochemistry, namely to aqueous composition for the treatment of TNFα associated disease in a mammal comprising an effective amount of an antibody or antigen-binding fragment thereof specifically binding to human TNFα, as well as to method for treating TNFα associated disease in a mammal with its use. Also disclosed is a lyophilized composition for the treatment of TNFα associated disease in a mammal, obtained by lyophilizing an effective amount of the above aqueous composition.
EFFECT: invention effectively treats TNFα associated diseases in a mammal.
16 cl, 12 dwg, 6 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα | 2018 |
|
RU2678120C1 |
| STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα | 2009 |
|
RU2567100C2 |
| STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFΑ | 2018 |
|
RU2704838C1 |
| HUMANIZING RABBIT ANTIBODIES USING A UNIVERSAL ANTIBODY FRAMEWORK | 2018 |
|
RU2696202C1 |
| HUMANIZATION OF RABBIT ANTIBODIES USING THE UNIVERSAL ANTIBODY FRAME | 2014 |
|
RU2652907C2 |
| HUMANISATION OF RABBIT ANTIBODIES USING UNIVERSAL ANTIBODY SCAFFOLD | 2009 |
|
RU2567006C2 |
| VEGF INHIBITING STABLE AND SOLUBLE ANTIBODIES | 2009 |
|
RU2531523C9 |
| STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF | 2009 |
|
RU2588467C2 |
| STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF | 2016 |
|
RU2648152C2 |
| STABLE AND SOLUBLE VEGF INHIBITING ANTIBODIES | 2018 |
|
RU2696972C1 |
